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ABSTRACT
“On Biotechnology, Philosophy and Society” is structured as an exploration of the formation of the bio-political 
Apparatus, within the fields of bio-politics, biotechnology, and bio (tech) Art. The paper examines the ontology of 
biotechnology, the economic fundamentals of biotechnology and value systems in the biotechnological era. The pa-
per also focuses on the political and economic spectrum, reflecting the socio-political consequences of the biotech 
revolution, and in this context looks into the connections between the organisation of bio-politics and bio-power 
along with the circumstances relative to the arts, sciences, and social struggles. One of the crucial aspects of this 
research is the analysis of how biotechnology is used for bio-political purposes, much in the sense of a political 
spectrum that reflects positions towards the social, economic and cultural consequences of the biotech revolution. Key words: Bio-political Apparatus, Bio-politics, Ontology, Bio-technology, Bio Arts (Bio-tech Arts), 
Phenomenology, Geopolitics, Globalism, GMOs (Genetically Modified Organisms), GE (Genetic Engineering), Bio-
Capitalism
SU BIOTECNOLOGIA, FILOSOFIA E SOCIETÀ
SINTESI
Il contributo “Su biotecnologia, filosofia e società”, strutturato come un’investigazione della formazione 
dell’apparato biopolitico nella sfera di biopolitica, biotecnologia e bio(tech)arte, si propone di esaminare l’ontologia 
della biotechnologia, i fondamenti economici della biotecnologia e i sistemi di valore nell’era biotecnologica. 
L’articolo mette a fuoco anche il complesso politico ed economico che rispecchiano le conseguenze della rivo-
luzione biotech, e in questo contesto studia i collegamenti tra l’organizzazione della biopolitica e del biopotere, 
nonché le circostanze relative all’arte, scienza e lotta sociale. Uno degli aspetti cruciali di questa ricerca è l’analisi su 
come la biotecnologia venga usata a scopi biopolitici, quasi come un campo politico che riflette le posizioni verso 
le conseguenze sociali, economiche e culturali della rivoluzione biotechnologica.Parole chiave: apparato biopolitico, biopolitica, ontologia, biotecnologia, bioarte (arte biotech), fenomenologia, 
geopolitica, globalismo, OGM (organismi geneticamente modificati), IG (ingegneria genetica), biocapitalismo
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Our age has shown us that technology and society 
are mutually constituted. In an era when life sciences 
merge with information sciences, the world reveals new 
concepts and practices in biotechnology. In fact, for one 
of the crucial fundaments of the biotechnological era, the 
medium of DNA, it has become irrelevant whether the 
code is recorded as an information code onto a hard disk, 
is found online or is stored in an e-coli culture living in a 
Petri dish. The very fact that the code is transferable makes 
issues of storage less important, but the understanding 
of the concept of transferability especially important. We 
are in fact subjected to processes whose full impact is 
hard to comprehend; however, this very impact has yet 
to be revealed, as a phenomenological approach vividly 
conveys. The discourses in biotechnology are evolving, 
showing us that the latest theoretical and practical de-
velopments have the potential to cause a tectonic shift in 
our culture, where the world is experienced at the inter-
section of the engineered and the biological. 
We have also began to understand that science and 
philosophy share motifs, metaphors and models with the 
arts. Historically, parallelisms between arts and sciences 
go a long way back, and can be traced at the beginning 
of the 20th century in the well known examples of Picasso 
and Braque coming up with the concept of Cubism at the 
same time as Einstein developed the concept of relativity. 
The influence of Henry Poincare’s Science and Hypothe-
sis on the artists of the age – especially in the chapters on 
the origins of geometry – seem to imply that the origins 
of Cubism are not limited to the arts. Namely, Poincare’s 
emphasis on the unconscious processing of information 
bears a striking similarity to Einstein’s and Picasso’s intro-
spection. The 20th century has also given us a fairly good 
understanding about the importance and functioning of 
visual thinking in both the sciences and arts. This has been 
thoroughly researched by the UK-based historian of sci-
ence Arthur I. Miller in ‘Insights of Genius: Imagery and 
Creativity in Science and Art’, and more so in his book 
‘Einstein, Picasso: Space, Time and the Beauty That Causes 
Havoc’. In the ‘Insights of Genius’, Miller rightly notes that 
the joint question of both the arts and sciences has been 
how to interpret the unseen world and go beyond the 
conventional constraints of visual imagery and language 
to dramatically transform the concepts of visual imagery. 
The level of interaction between the arts, sciences, and 
technology has been steadily increasing over the past 
few decades, indicating the tendency of artists to as-
sume the research roles normally attributed to scientists, 
enabled by their residencies at academic and scientific 
institutions (e.g. Joe Davis at MIT, Adam Zaretsky at Rens-
selaer Polytechnic Institute, Tissue Art & Culture Project 
at SymbioticA, School of Anatomy, University of West-
ern Australia, etc.). Perhaps even more important than the 
actual mastery of scientific and technologic processes is 
the tendency of biotech artists to become highly aware 
of the necessity to collaborate with scientists and tech-
nologists. Both disciplines have a lot to achieve by col-
laborating with each other and conveying, in regard to 
the understanding of the fundamental concepts, methods 
and practices of living and physical systems, in a process 
that does not seem to be dry mathematical, but rather 
one that is driven by intuition and visual thinking, in both 
the arts and sciences. ONTOLOGY OF BIOTECHNOLOGY
We are certainly witnessing the advent of biotechno-
logy today, which creates a definitive sense of urgency 
concerning the task of understanding it and the ways by 
means of which it shapes contemporary society. Nume-
rous ontological questions about the nature of biote-
chnology come into being, such as is the case with the 
“technological determinism”, which is characterised by 
looking into biotechnology as a tool or artefact, which 
exists for the achievement of certain objectives desired 
by humans because of its determinant effects and con-
texts of use. However, the complexity of developments 
in biotechnology renders technological determinism ina-
ppropriate because of the already established complex 
relations between biotechnology and society. Its pro-
duction processes and values promise to have the most 
profound epilogue in terms of how they directly relate to 
the understanding and programming of life itself. Eugene 
Thacker says that in biotechnology ontological questions 
immediately fold into questions that are social, econo-
mic and cultural. According to Thacker, biotechnology is 
directly linked to globalism, since today it takes place on 
a global level, whether in terms of exchanging biologi-
cal information, controlling epidemics, deterring biologi-
cal attacks or the standardisation of intellectual property 
laws (Thacker, 2006). The point stated above clearly points 
out that bio-capitalism is very much dependent upon the 
outcomes of globalism. Namely, the growth of financial 
capital generated by the field of biotechnology as well as 
the governmental funding which matches it, purely posi-
tion it as one of the pillars that globalism thrives on. The 
generated profits determine largely the relationship be-
tween the developed world and the ‘third world’, which 
include the expansion of biotechnological international 
companies into the third world, the rampant collection 
and patenting of biological materials of indigenous po-
pulations, etc. The situation we have today is a proof that 
biotechnology is the outcome of a complex and socially 
situated process. According to Biljker, Pinch, and Hug-
hes, various political, socio-cultural, and economic for-
ces shape the options that are suggested for technology 
in general. The designing of the entire process therefore 
undergoes various stages, including the removal of al-
ternative technological options. Therefore it is not only 
that the technology impacts on society but also that the 
technology is itself already the outcome of complex and 
subtle processes or indeed that technology is itself al-
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ready socially constructed (Biljker, Pinch, Hughes, 1987). 
This argument is strengthened by the actual utilisation of 
a certain technology, which is often used differently than 
was imagined or intended by its creators, making obvious 
the reciprocal nature of the relationship in which techno-
logy and society co-construct each other.
Although they are quite valuable, the above-
mentioned views do not fully explain the entire range 
of developments in biotechnology. It is therefore 
necessary at this point to turn to phenomenology, which 
makes the above noted approaches obsolete (for the 
phenomenologist, technology is a condition of society). 
In this respect phenomenology offers a variety of 
approaches provided by Heidegger, Dreyfus, Borgmann, 
Winograd and Ihde among others, with a common view 
that technology and society co-constitute each other by 
comprising each other’s reciprocal and ongoing condition 
or possibility for being what they are. In this respect we 
can point to Martin Heidegger’s phenomenology as 
a fundamental critique of the technological attitude, 
underlining the necessity of another beginning of thinking 
(Heidegger, 1977) and Albert Borgmann’s technological 
attitude, as manifested in our contemporary relationship 
with particular technologies (biotechnology is of particular 
concern). For Heidegger, technology is not just an 
artefact but it already emerges from a prior technological 
attitude towards the world (Heidegger, 1977). Heidegger 
claims that “just as an essence of a tree is not itself a 
tree that can be encountered among all other trees, 
so the essence of technology is not itself something 
technological”. What Heidegger refers to at this point 
is the isolation of a particular “understanding of being” 
that makes technology possible. Heidegger’s view (and 
the view taken by phenomenology generally) is that the 
society and technology co-constitute each other and 
are in a permanent condition of being what they are. 
Heidegger identifies Plato’s articulation of techne as the 
foundation upon which contemporary technology builds. 
Therefore Heidegger insists on a certain isolation of a 
particular understanding of being, which allows for the 
existence of any technology. For Heidegger, technology 
has a dual significance: as an extreme danger threat-
ening man to enter into a more original revealing, but 
also as a redeeming power (The Question, 337), which is 
there for man to recapture the original essence of sci-
ence (The Question, 333), making “techne” the originat-
ing and final point of human existence. In particular, he 
identifies Plato’s articulation of techne as the foundation 
upon which contemporary technology builds. This 
creates for us the paradoxical situation in which techne 
represent the beginning and end, an overwhelming threat 
to human existence. Heidegger defines the essence of 
modern technology as gestell or enframing. According 
to Heidegger, enframing refers to the urge of humans 
towards revelation of aletheia (truth) as ever-present. 
For Heidegger, enframing is the essence of modern 
technology because modern technology is rooted in 
techne: it is a means of sourcing true forms and ideas 
that exist prior to the figures we perceive. According to 
Heidegger, enframing is a determining action, from which 
the essence of all history is derived.
With regard to our relationship with technology, 
Albert Borgmann takes up a ‘free’ position, opposed to 
the ‘enframed’ position taken by Heidegger. Although 
Borgmann generally agrees with Heidegger that modern 
technology is a phenomenon that tends to frame our 
relation with things, he nevertheless argues that modern 
technology frames the world for us in terms of its devices. 
He understands this to be the point at which modern 
technology as devices conceals the full referentiality 
of the world and the necessary effort for the devices 
to be made available for use (Borgmann, 1984). This is 
the way in which devices “de-world” our relationship 
with things by disconnecting us from the full actuality 
of things. Borgmann therefore generally points towards 
the emergence of a device-based mood, due to our 
increasing reliance on devices that relate us to the world 
in a manner characterised by disengagement. He also 
gives a dire warning that our moral obligation is not 
to settle mindlessly into the convenience that devices 
may offer us but, on the contrary, points to Heidegger’s 
argument that we may become devices of our devices 
(Borgmann, 1984).
Heidegger’s concept of enframing can be deciphe-
red today by using Eugene Thacker’s trinity of ‘encoding, 
recoding, decoding’ as representing the primary activities 
of biotechnology. Today the dissemination of the biolo-
gical through information networks on demand or due 
to necessity creates a new situation in which we appre-
hend the biological in digitally-intermediated terms as a 
digitally packaged commodity. Thacker points to notions 
of the biological stock being simultaneous comprised of 
property and information, as having the traits of materia-
lity and immateriality and as existing as deployments of 
life, which are being, shifted from body to body, body to 
code and code to body. Thacker also sees this tripartite 
division in politico-economic terms. In a sense, encoding 
is synonymous with production, for it is by means of the 
process of encoding the biological that the biotech in-
dustry is able to accrue profits (as intellectual property, 
as a proprietary database or software). Recoding is then 
synonymous with distribution (and its related term, cir-
culation), for the practices of bioinformatics, database 
management and computer networking are predicated 
on the ability of biological information to be widely dis-
tributed and circulated. Finally, decoding is synonymous 
with consumption in the sense that – in a medical sense 
at least – it is in the final output or re-materialisation of 
biology that biological information is used, consumed, or 
incorporated into the body (Thacker, 2006).
Don Ihde’s post-phenomenological position stands 
in stark contrast to Heidegger’s phenomenology of te-
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chnology and represents its deep critique in regard to its 
very genesis – the genesis of technology. Ihde defines 
post-phenomenology as an inquiry into ways in which 
technology is embodied. His post-phenomenology sheds 
new light on the relation that is being established bet-
ween humans and technology. By focusing especially on 
the bodily condition, it succeeds in providing a meanin-
gful taxonomy, providing an account of many everyday 
technology relations in a manner that can facilitate our 
considerations of the social and ethical implications of 
information technology. Ihde characterises four different 
I-technology-world relations in terms of ‘embodiment’ 
relations, ‘hermeneutic’ relations, ‘alterity’ relations and 
‘background’ relations (Ihde, 2002). Basically, the “lived 
body” becomes immersed in technologically designed 
environments.
In order to gain a better understanding the phenome-
nological position on technology it is worth referring to 
Max van Mannen’s division of “lived experience” into the 
categories of: “spatiality” (referring to the “lived space”), 
“corporeality” (referring to the “lived body”), “temporality” 
(referring to the “lived time”) and “relationality” (referring 
to the “lived other”). 
We can deduce that biotechnology structures society 
but equally that society forms biotechnology. The cha-
racteristics of these interactive processes are engrained 
into the general modus operandi with regard to standard 
processes and practices in biotechnology as well as in 
accepted modes of thinking about biotechnology. In its 
response to the positions stated above, the research is 
almost certain to impact our opinion on social and ethical 
implications of biotechnological developments in view of 
the bio-political concerns about various uses of biotech-
nology in economy, government, education, culture and 
art.
The transition of biology from a life science to an in-
formation science (assisted by the integration of biology 
and informatics) fosters various new debates on ethical, 
economic, political and cultural realms, investigated thro-
ugh various bio-semiotic, phenomenological, post-struc-
tural and other lenses, aimed at investigating the newly 
created socio-political system in which new modes of 
regulation management and control are predetermined 
by effectively unifying the natural with the synthetic. Ad-
ditionally, the convergence of biotechnology with com-
munication technologies in a global network certainly 
allows for the articulation of academic and public disco-
urses that investigate the changing scope of global power 
relations as well as governance policies. The merging of 
information technologies with biotechnologies has the 
power to change the core nature of global relations as 
well as various elements therein by proliferation of global 
intellectual property policies, as well as by the developing 
of genomic databases (e.g. the DNA Databank in Japan, 
GenBank in the US, etc.).
Although there is a long historic line of thought lea-
ding to modern biotechnology, we can define it today as 
the application of scientific and engineering principles to 
the processing of materials by biological agents to provi-
de goods and services. Its major discoveries belong well 
and truly within the parameters of the twentieth century. 
The culminating point around issues of biotechnology 
was the start of genetic engineering and in particular Ja-
mes Watson’s and Francis Crick’s 1953 discovery of the 
structure of DNA1 and Cohen and Boyer’s 1973 discovery 
of the recombinant DNA technique by which a section 
of DNA was cut from the plasmid of one E. coli bacte-
rium and transferred into the DNA of another. However, 
as paradoxical as it might seem, this development had 
even been delayed, due to the fact that major discove-
ries had been overlooked for substantial periods of time, 
such as was the case with Gregor Mendel’s findings 
about heredity from 1865/6, which were not revisited until 
the beginning of the twentieth century. The same is true 
for the 1953 discovery of the DNA structure, since it had 
been overlooked for decades. In fact, in April 1953, the 
scientific paper in which James Watson and Francis Crick 
presented the structure of the DNA-helix, describing it as 
a “structure [having] novel features, which are of consi-
derable biological interest”. This is an obvious understa-
tement and certainly doesn’t come anywhere close to 
the true significance of the discovery, best defined in a 
later explanation given by Francis Crick in more dramatic 
terms: “We have discovered the secret of life”. This lat-
ter statement seems to be closer to the true revelation 
of aletheia (truth) as for the past 50 years we have been 
experiencing constant breakthroughs, all of which have 
the discovery of the DNA structure as their core. This po-
sition naturally created a response from the cultural field 
when Gordon Rettray Taylor wrote the “Biological Time 
Bomb”, in which Kornberg’s discovery of the biochemi-
cal replication of the viral gene was seen as a doomsday 
scenario. The publisher warned that within ten years you 
would be able to marry a semi-artificial man or woman, 
change your memories, live up to hundred and fifty ye-
ars and choose the sex of your children – if the scientific 
revolution didn’t destroy us first. This was the age when 
art – and especially the moving image – has followed 
a history of involvement with science fiction (and here 
we should remember not only Star Trek, but also Woody 
Allen’s ‘Sleeper’, a genre which would be continued later 
with Cronenberg’s ‘The Fly’, ‘Matrix’, etc.). 
By looking into the past and forecasting the future, 
the US artist George Gessert says: “From the 18th thro-
ugh the 20th centuries technological developments led 
to revolutions. I think that in the 21st century change 
1 James Watson and Francis Crick shared the Nobel Prize in Physiology or Medicine with Maurice Wilkins in 1962 for accomplishing to 
solve one of the most important of all biological riddles.
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will be generated less by technological developments 
than by their unintended consequences such as climate 
change, species loss and ecological collapse. A key role 
of art will be to produce ways of thinking and feeling 
that point toward more sustainable economic and so-
cial systems”.
Rifkin’s warning about the price which we have to 
pay for the development of biotechnology and genetics 
presents the gamut of issues which we will have to face 
as society, especially with the engineering of new life 
forms, the creation of cloned beings, the engineering 
of beings even before they are born and the patenting 
of the genetic pool of indigenous populations. In this 
respect we certainly find ourselves at a stage of deve-
lopment in which we are able to ask more questions 
about economy, politics and culture than we have an-
swers.ECONOMIC FUNDAMENTS OF BIO-TECHNOLOGY
In “The Global Genome: Bio-technology, Politics 
and Culture” Eugene Thacker depicts a cultural system, 
which is being constructed according to the rationale of 
economic benefit. He refers to the political economy of 
the genetic body, understanding life as reprogrammable, 
instrumentalised and networked. Thacker addresses the 
mobility of biology across media in which production, 
distribution and consumption define the contemporary 
model of biology and life itself.
Economic benefits – alongside economic incentives 
– play a large role in the development of biotechnology. 
We are currently able to detect a certain political eco-
nomy encompassing biological advances. According to 
Chase-Dunn, Kawano and Brewer, international econo-
mic integration today (trade and investment globalisation) 
is relevant for understanding the economic consequen-
ces of biotechnology. If financial instability or enviro-
nmental problems cause the world economy to stagnate 
or if conflicts increase to the point that economic pro-
duction and exchange are greatly reduced, comparative 
advantages due to biotechnology would be postponed 
and international diffusion would have a greater chance 
to reduce technological rents.
The possibility of the economic benefits that can be 
provided by biotechnology has had the close attention of 
successive US governments for more than thirty years. 
The re-establishment of American economic hegemony 
is certainly tending to base itself on developments in the 
biotechnologies and information technologies. Several 
studies have been commissioned by the US Congress to 
compare the competitiveness of the US with that of Euro-
pean countries and Japan. In 1984, a study demonstrated 
that the United States has huge advantages over possible 
competitors; accordingly, it embraced additional funding 
(private and public) for biotechnology. These findings co-
incided with an actual change in terms of the acquisition 
by the United States of an increasing share of world bio-
tech markets from 1992 onwards.
Christopher Chase-Dunn, Richard Niemeyer and Juli-
ann Allison point out to the fact that since the early 1980’s 
several major efforts have been made to study the deve-
lopment of the biotechnology sector within the United 
States:
The creation of new technologies, as well as the sci-
ence involved in their production, is essential to the 
development of long-term economic growth and in-
ternational competitiveness.
No new area of science or technology holds greater 
promise or potential for long-term economic growth 
than biotechnology.
Relevant data regarding biotechnology must be 
gathered so as to develop timely and accurate statisti-
cal measures of the economic scope and size of the 
US biotechnology industry, the level of growth, trade 
and performance in biotech markets, the level of R&D 
and venture capital both in use by and available to bi-
otech companies, as well as the nature of existing and 
potential barriers to future growth. Data of this nature 
will play an essential role in the ability of lawmakers 
and policy analysts to effectively promote the future 
growth and development of the US biotechnology in-
dustry (Chase-Dunn, Niemeyer, Allison, 2006).
The contemporary debates about genetically modifi-
ed organisms and the pro- and contra- stances of prota-
gonists and activists in this battle that we are witnessing 
possess an argumentative character that seems to be 
above all political and economic as blocs of countries 
line up according to their strategic requirements. Curren-
tly the United States, Argentina, Brazil, and Canada have 
99 per cent of total global acreage devoted to GM crops. 
We can also say that the Chinese government supports 
plant biotechnology (one of the reasons being that China 
has to feed almost 20% of the world’s population but only 
possesses 7% of the world’s cultivable land). China has 
adopted a promotional policy towards biotechnology by 
taking a leading role between Asian and developing co-
untries in the research and adoption of plant biotechno-
logy. According to a recent study on the global diffusion 
of plant biotechnology (Runge, 2004), it is second only 
to the USA in terms of the amounts it invests in crop bi-
otechnology research. Its robustness makes it an impor-
tant player in the biotechnological field, one able to con-
ceptualise and realise independent policies. However 
Europe’s moratorium on the approval of new GM imports 
and its other anti-GM regulations worry the farmers and 
ministers of developing countries, who fear the loss of 
Europe as a market. Paarlberg says that “these regulations 
are the single most powerful force in implementing GM-
-free crops around the world. According to Paarlberg, not 
one African country outside of South Africa has approved 
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any GM crop for commercial planting (Paarlberg, 2008). 
Paarlberg’s opinion about European regulation being of 
utmost importance for the African countries certainly se-
ems plausible as Europe represents the primary market 
for African products. We can also point to the situation 
in Asia in which only GM cotton has been legalised for 
cropping, strongly benefitting China, Indonesia and India, 
by reducing the amount of crop spraying required. Me-
anwhile, opponents to the use of GMOs propose a wor-
ldwide moratorium. In terms of this proposal, Paarlberg 
argues that the acceptance of this position would only 
hurt developing countries, as GM crops could make the 
difference between poverty and prosperity due to GM 
crops being pest-resistant, drought-resistant and/or nitro-
gen-fixing and as such able to slow the chronic increases 
in hunger and agricultural poverty that afflict sub-Saharan 
Africa, caused by factors such as insects destroying up to 
45 per cent of the maize crop in Kenya every year. 
Aside from Robert Paarlberg’s argumentation that the 
tide has already turned for food and feed crops and the 
example of Monsanto not going ahead with the program 
of GM maize, rice, or soybeans in China, a brief analysis 
will demonstrate that dedicated resources to support bi-
otechnological industries exist all around the world. Ac-
cording to Burrill and Company, an industry investment 
bank, over $350 billion has been invested in biotech since 
the emergence of the industry with global revenues rising 
from $23 billion in 2000 to more than $50 billion in 2005. 
Proving the point that biotechnology is a global pheno-
menon, practically all regions of the world have shown 
strong growth trends, with Latin America recording the 
greatest growth. It is important to note that the advent of 
biotechnology has occurred with the collapse and shift 
of economic and political systems in most of the soci-
alist economies (the Soviet Union and Eastern Europe), 
the change of the economic systems in the non-aligned 
countries as well as in China and the opening up of India 
to multinational companies. This very impressive grow-
th of the biotechnology and the newly acquired markets 
tend to be accelerated by the use of other technologies 
such as new production software, bio-informatics, Inter-
net technologies, surveillance technologies, etc. This de-
velopment is additionally followed by the setting up of 
contemporary labour processes across the globe (e.g. in 
Costa Rica, Thailand, Indonesia, India, etc.) and by sec-
tioning their different parts or stages according to the 
necessities of the market and international production 
network monopolies. However, as early as 2007/8, this 
accelerating development – as often occurs in the cycles 
of capitalism – ended up in a reversal of fortunes of bio-
tech companies. This was of grave importance, but, addi-
tionally, it is not only the economic impact, which was of 
consequence. When reflecting on the above noted issu-
es about the development of bio-capitalism in genetics, 
biotechnology, and synthetic/artificial life, we should have 
in mind Jeremy Rifkin’s nagging question “At what cost?”, 
as well as other important questions about the new ge-
netic commerce which brings about more troubling issu-
es than any other economic revolution in history, and the 
risks involved in the designing of more perfect animals 
and humans (Rifkin, 1998). Genetic engineering remains a 
contested subject with the development of gene therapi-
es, stem cell research, cloning, and genetically-modified 
food. The last several decades have made us more aware 
of the complex structures and processes involved in bio-
technology, addressing issues as diverse as the social and 
political context surrounding biotechnology; the relation-
ship between ethics and biotechnology (e.g. the ethical 
implications of genetic engineering); the background to 
scientific processes, their essence, and their spectacular 
nature; the complex relationships between science and 
culture; and the politics of the discipline of biotechnology. 
In an interesting observation, Eugene Thacker has inver-
ted Timothy Leary’s notion that computers are the drugs 
of the 90s, saying that ‘for the biotech industry, drugs are 
the computers of the 21st century’. This creates for us a 
significant paradigm shift.
Patenting started to become an important issue in bi-
otechnology when the US Supreme court decided that an 
oil guzzling microbe developed by General Electric was 
patentable. This signalled a high demand for chemical 
and pharmaceutical companies in regard to patenting life 
forms. Various patents concerning about gene sequen-
ces, human and animal cell lines, indigenous genes and 
knowledge have been contested and ultimately accepted 
by the courts. A somewhat paradoxical situation occurs 
at the very core of patenting procedures. In order for pa-
tents to go though the European and US patent offices, 
biotech companies claim that the GMOs they produce 
are fully artificial and consequently not found in nature. 
Eugene Thacker says that this claim is the foundation for 
fulfilling the patentability criteria in the United States and 
the European Union: that patents be “new, useful and 
nonobvious”. Those against genetic patents argue that 
by definition “life itself” cannot be subject to patent laws 
because “life itself” is synonymous with “nature”, or so-
mething that already pre-exists human intervention. The 
claim that a genetic sequence or GMO is artificial under-
scores the “tech” part of the biotech: it is in some non-
trivial way the result of human intervention, industry and 
technology. But we also see another contradictory claim 
emerging from many of the very same companies that 
are ostensibly in the business of patenting and licensing. 
This claim is the exact opposite of the first: that these new, 
useful, and non-obvious inventions are “natural” and thus 
safe for the environment, for the human body, for agricul-
ture and for medical application.
This situation in terms of patenting has been addres-
sed with a cultural response which was provided among 
others by the US artist Diane Ludin with her project i-BPE 
(iBiology Patent Engine). The project was originally based 
on the surrealist game “Exquisite Corpse” offering Inter-
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net users a framework to build a resource against the 
distressing militarism inherent within the US patenting sy-
stem today. That framework is a text-based interface that 
asks users to begin building a patent. The patent can be 
built from scratch or by using a sample from the United 
States Patent and Trademark Office’s database of curren-
tly granted patents (Ludin, 2008).
On another level, it is worth noting that some current 
developments in biotechnology are revolutionary due 
to the general access to biotechnological tools enabled 
through various DNA DIY Kits. Foundations such as The 
KlaasKids Foundation and the State of California DNA La-
boratory have created a Do-It-Yourself DNA Collection 
Kit using common household items, in which parents can 
sample and store their children’s DNA with total confi-
dence but without the unnecessary expense of purcha-
sing commercial DNA kits which cost between $5.00 and 
$20.00 per child (Klass Kids, 2012). Other DNA DIY kits 
include those offered by chemists that allow the paternity 
of children to be established without the usual recourse 
to the legal system.
The Internet also proves useful in regard to promoting 
DNA Ancestry Projects (Genetic Geneaology, 2012), So-
cial Networking web sites such as 23 and Me (23andMe, 
2012), as well as offering professional sites for the more 
advanced in DNA research, such as: GenBank®, which 
is the NIH genetic sequence database (GenBank, 2012) 
and the Basic Local Alignment Search Tool (BLAST, 2012), 
which finds regions of local similarity between sequences 
comparing nucleotide or protein sequences to sequen-
ce databases and calculates the statistical significance of 
matches. BIOTECHNOLOGY AND THE ARTS – SCIENCES VS. HUMANITIES
The relationship between biotechnology and the Arts 
can justifiably be seen as a curious one, as we can cur-
rently only observe the tip of the iceberg. Still lurking in 
the depths are some of the most difficult unresolved que-
stions arising from the breakdown of communications in 
society, such as the issue of the relationship between the 
arts and the sciences, which has plagued humanity thro-
ughout the greater part of the twentieth century. This was 
described by the author C. P. Snow as the rift between 
“Two Cultures” in his celebrated 1959 lecture series of 
that title. However, Snow also saw in this breakdown a 
chance for humanity: “The clashing space of two subjec-
ts, two disciplines, two cultures, – of two galaxies, so far 
as that goes – ought to produce creative chances. In the 
history of mental activity that has been where some of 
the breakthroughs came. The chances are there now. But 
they are there, as it were, in a vacuum, because those in 
the two cultures can’t talk to each other. It is bizarre how 
very little of twentieth century science has been assimila-
ted in twentieth century art.”
Generally speaking, people have been educated ei-
ther in the sciences or humanities – but not both. This task 
of bridging the gap between the disciplines is therefore 
made very difficult, as in the analysis of both one has to 
deal with the essence, spectacle and background of sci-
entific processes, the aesthetic qualities of works of art, 
the complex relationship of science and culture, as well 
as the social and political context surrounding art and 
biotechnology. 
Biotech art has a prominent place with regard to brid-
ging this quite obvious gap from the “two cultures” of 
modern society – the sciences and the humanities. Snow 
sees the breakdown of communication between the two 
cultures of modern society as a major hindrance to sol-
ving the world’s problems of art and science – along the 
interface of the biological (which is both “ultimate objec-
tivity” in the hands of science – “biological facts” – and 
“ultimate subjectivity” as the most intimate seat of perso-
nal feeling and emotion – the irreducible humanist basti-
on of “feelings”).
This complexity is further accentuated since one has 
to take into account the fact that biotechnology also ad-
dresses biopolitical issues, the ethical implications of ge-
netic engineering, the relationship between ethics and 
biotechnology, etc. 
The artistic strategies presented through various 
approaches regarding our reflection upon power relati-
ons (bio-political conflicts in the real and virtual worlds 
increasingly involve governments; NGOs and corpora-
tions), including such diverse factors as: energy control; 
the choice of fuel materials; alternative energy sources; 
nuclear energy; the control of the biological; the inheri-
tance and programmability of life; ecological visualisati-
ons; food miles entropy; the causes and consequences 
of global environmental change; carbon offsets; eco 
footprints; the sustaining of the environment; macro and 
micro ecology; current topics in applications of microbi-
ology in biotechnology; the dimensions of live matter; the 
relation to the relation to life, genetically modified foods; 
death; and appearance, etc.
Indeed, biotech art is a wide-ranging subject, building 
on both the arts and sciences (biology and biotechnolo-
gy), with abundant material coming from both cultures. 
Therefore biotech artists have been seen as instrumental 
in bridging this gap between the arts and sciences. Joe 
Davis, the American artist and pioneer of biotech art, be-
lieves that Snow’s perspective is outdated: “The two can 
no longer be absolutely separated. Like science, art is a 
quest for knowledge. Few recall that for thousands of ye-
ars, art was a principal instrument used by Homo sapiens 
to undertake the Apollonian search for secrets of God 
and nature. Only in recent centuries have special injunc-
tions been adopted which proscribe artistic activities that 
might be confused with research and scientific inquiry. 
Students of art in our own era will generally have no idea 
that artists contributed to the invention of mathematics, 
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astronomy, chemistry, physics and biology. This construc-
ted separation of art and science has left little room for 
individuals who work outside contemporary frameworks 
of thought and language. Scholars of the humanities now 
acknowledge that this separation of arts and sciences 
was an artificial one perpetuated by centuries of history 
that turned metaphysics into the foundation of all things 
artistic. Yet, the machinery of this historical artificiality and 
its categories has assumed a kind of de facto reality. Until 
we can learn to think without the modern classifications 
of art and science, it will be difficult to encounter bor-
derlines, interspaces and hybrids” (in interview with the 
author).
Davis goes on to say that he believes that the arts have 
been slowly moving away from this division for at least 
several decades: “I am simply too impatient to wait for art 
to fully recover its former scope. I would rather explore a 
role that still remains unknown to us: neither as an artist 
nor as a scientist (designations I consider exchangeable 
in my personal practice). An artist-scientist is both free 
enough to tackle absurd questions and disciplined enou-
gh to be scientifically rigorous about the way the work is 
carried out. There is a chance, where it is possible to both 
dream and act, that opposition between Romantic and 
Constructivist notions can finally be resolved. In the first 
century BCE, Marcus Vitruvius, the great Roman artist and 
architect and namesake of Leonardo da Vinci’s Vitruvian 
Man wrote that a student of art ‘… should be a good 
writer, a skilful draftsman, versed in geometry and optics, 
expert at figures, acquainted with history, informed on the 
principles of natural and moral philosophy, somewhat of 
a musician, not ignorant of the sciences both of law and 
physic, nor of the motions, laws, and relations to each 
other of the heavenly bodies. Since, therefore, this art is 
founded upon and adorned with so many different sci-
ences, I am of the opinion that those who have not, from 
their early youth, gradually climbed up to the summit, ca-
nnot, without presumption, call themselves masters of 
it.’ I look at this history with wonder and awe and I hear 
pronouncements that we will never again hold such gre-
atness in our grasp. But I recognize that greatness is only 
a matter of will and I think about it every time I meet an 
artist who says, ‘I decided to become an artist because I 
hate math.’” 
On the other hand, the British artist Gina Czarnecki 
doesn’t believe that the gap is being bridged as much 
as is now being argued, made credible again and being 
seen as an important and interesting space. According 
to Czarneck, there never really was a gap but just the 
perception of one. She believes that there is increasing 
awareness of the need for both specialists and generalists 
in any field. She says: “Science, technology, culture, inno-
vation and their associated socio-political drivers are in-
terrelated and there is an increased acknowledgement of 
the mutual evolution and the spaces between. However, 
one of my concerns in the UK is education, and whilst it 
appears we are heading to a place where the space bet-
ween art and science is being increasingly professionally 
acknowledged, and therefore will grow, the education 
system is sprouting specialist secondary schools which 
gear themselves to be specialists in maths and compu-
ting, sciences, or humanities. My children at ten will have 
to make a decision on what path they take and it beco-
mes vital that alternative models of what people can do 
are there for these children rather than the division and 
classification of thinking” (in interview with the author).
Gary Cass, the Australian biologist turned artist, is ab-
solutely convinced that most of the world’s universities, 
the bastion of all knowledge, have recognised the va-
lue of cross disciplinary research and that includes the 
arts sciences crossovers. “My new workshops focus on 
not only artistic creativity but the scientific creativity. The 
science world is recognising the need for their world to 
become more creative. To deal with an unknown future 
and the possible problems we as a society may face, we 
will need the sciences to become more creative. And of 
course this may involve the meeting of two diverse cul-
tures like the arts and sciences. I believe we have bridged 
the gaps, albeit slightly, but it is a great start in the right 
direction. Further acceptance of the arts by the sciences 
and especially the science funding bodies, in particu-
lar the need for philosophical viewpoints and creativity 
are definitely required. But it will also require the arts to 
accept scientific beliefs and position“. (in interview with 
the author.)
Finally, it is worth listening the voice of the pioneer of 
biotech arts Joe Davis who believes that “society is stru-
ggling to integrate new knowledge in life sciences into 
older frameworks. Scaffoldings that support religious, le-
gal, corporate and other social/economic structures will 
inevitably have to be reconfigured.”
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O BIOTEHNOLOGIJI, FILOZOFIJI IN DRUŽBI
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POVZETEK
Prispevek »O biotehnologiji, filozofiji in družbi« kritično obravnava najnovejša dogajanja na področjih biopo-
litike, biotehnologije in biotehnološke kulture in umetnosti, preučuje njihove teoretične temelje ter sledi poteku 
njihovega razvoja v zadnjih dveh desetletjih 20. stoletja.
Besedilo je strukturirano kot raziskava znotraj biopolitike, biotehnologije in bio(tehnološke)umetnosti. Osredo-
točena na politični in ekonomski spekter, raziskava odseva družbeno-politične posledice biotehnološke revolucije 
in v tem kontekstu preučuje tudi povezave med usklajenostjo biopolitike in biomoči ter okoliščine, ki zadevajo 
umetnost, znanost in družbeni boj, pri čemer biotehnološko kulturo predstavi skozi širok nabor izkušenj in vplivov.
Namen prispevka je predvsem razjasniti novo družbeno matriko delovanja, ki se je očitno pojavila z razvojem 
številnih sil v biotehnologiji in povzročila aktualne ekonomske (biokapitalistične) in kulturne spremembe (biokul-
tura, bioumetnost).
Članek spregovori tudi o bio(tehnološki)umetnosti, saj so umetniki že precej zgodaj začeli ustvarjati z biotehno-
logijo in so v odziv na razvoj dogodkov na področju biopolitike in biotehnologije razvili tudi pomembne diskurze.
Cilj prispevka je jasno ponazoriti oblikovanje globalnega biopolitičnega aparata, ki tako vsebuje nove vektorje 
moči v odnosu do družbenih, političnih, ekonomskih in administrativnih mehanizmov, kot tudi strukture znanja, ki 
so sposobne ustvarjati, ohranjati, pa tudi uničiti sodobno družbo.Ključne besede: biopolitični aparat, biopolitika, ontologija, biotehnologija, bioumetnosti (biotehnološke umetnosti), 
fenomenologija, geopolitika, globalizem, GSO-ji (gensko spremenjeni organizmi), GI (genski inženiring), 
biokapitalizem
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